Search Results - "Fernandes, Ana I"

Refine Results
  1. 1

    Polymers Enhancing Bioavailability in Drug Delivery, 2nd Edition by Fernandes, Ana I

    Published in Pharmaceutics (01-11-2023)
    “…This Special Issue continues the previously published work [...]…”
    Get full text
    Journal Article
  2. 2

    Polymers Enhancing Bioavailability in Drug Delivery by Fernandes, Ana I, Jozala, Angela F

    Published in Pharmaceutics (01-10-2022)
    “…A drug’s bioavailability, i.e., the extent to and rate at which it enters the systemic circulation, thus accessing the site of action, is largely determined by…”
    Get full text
    Journal Article
  3. 3

    Amorphous and Co-Amorphous Olanzapine Stability in Formulations Intended for Wet Granulation and Pelletization by da Costa, Nuno F., Daniels, Rolf, Fernandes, Ana I., Pinto, João F.

    “…The preparation of amorphous and co-amorphous systems (CAMs) effectively addresses the solubility and bioavailability issues of poorly water-soluble chemical…”
    Get full text
    Journal Article
  4. 4

    Exploring Environmental Settings to Improve the Printability of Paroxetine-Loaded Filaments by Fused Deposition Modelling by Figueiredo, Sara, Fernandes, Ana I, Carvalho, Fátima G, Pinto, João F

    Published in Pharmaceutics (01-11-2023)
    “…The successful integration of hot-melt extrusion (HME) and fused deposition modelling (FDM) depends on a better understanding of the impact of environmental…”
    Get full text
    Journal Article
  5. 5

    Potential Herb-Drug Interactions in the Management of Age-Related Cognitive Dysfunction by Auxtero, Maria D, Chalante, Susana, Abade, Mário R, Jorge, Rui, Fernandes, Ana I

    Published in Pharmaceutics (19-01-2021)
    “…Late-life mild cognitive impairment and dementia represent a significant burden on healthcare systems and a unique challenge to medicine due to the currently…”
    Get full text
    Journal Article
  6. 6

    Downstream Processing of Amorphous and Co-Amorphous Olanzapine Powder Blends by da Costa, Nuno F, Daniels, Rolf, Fernandes, Ana I, Pinto, João F

    Published in Pharmaceutics (23-07-2022)
    “…The work evaluates the stability of amorphous and co-amorphous olanzapine (OLZ) in tablets manufactured by direct compression. The flowability and the…”
    Get full text
    Journal Article
  7. 7

    Quantification of theophylline or paracetamol in milk matrices by high-performance liquid chromatography by Fernandes, Tânia A.P., Aguiar, João P., Fernandes, Ana I., Pinto, João F.

    Published in Journal of pharmaceutical analysis (01-12-2017)
    “…A simple, accurate and sensitive high-performance liquid chromatography (HPLC) method was developed, validated and applied to the determination of either…”
    Get full text
    Journal Article
  8. 8

    The Uses of Coffee in Highly Demanding Work Contexts: Managing Rhythms, Sleep, and Performance by Pegado, Elsa, Rodrigues, Carla, Raposo, Hélder, Fernandes, Ana I.

    Published in Social sciences (Basel) (01-08-2022)
    “…This paper presents a sociological approach to coffee consumption as a performance management strategy in work contexts, particularly in professions with…”
    Get full text
    Journal Article
  9. 9

    In Situ Co-Amorphization of Olanzapine in the Matrix and on the Coat of Pellets by da Costa, Nuno F, Azevedo, Raquel F, Lopes, João A, Fernandes, Ana I, Pinto, João F

    Published in Pharmaceutics (24-11-2022)
    “…In situ amorphization is a promising approach, considered in the present work, to enhance the solubility and dissolution rate of olanzapine, while minimizing…”
    Get full text
    Journal Article
  10. 10
  11. 11

    The effect of polysialylation on the immunogenicity and antigenicity of asparaginase: implication in its pharmacokinetics by Fernandes, Ana I, Gregoriadis, Gregory

    Published in International journal of pharmaceutics (17-04-2001)
    “…Erwinia carotovora l-asparaginase was conjugated via the ∈-amino groups of its lysine residues with colominic acid (CA) (polysialic acid) of average molecular…”
    Get full text
    Journal Article
  12. 12

    Measurement of the amorphous fraction of olanzapine incorporated in a co-amorphous formulation by da Costa, Nuno F., Fernandes, Ana I., Pinto, João F.

    Published in International journal of pharmaceutics (15-10-2020)
    “…[Display omitted] •Olanzapine was successfully co-amorphized using saccharin as a co-former.•Spectroscopic tools were effectively used to predict the amount of…”
    Get full text
    Journal Article
  13. 13

    Sexual and reproductive health: the science behind supplementation in aging by Figueiredo, Alexandra, Fernandes, Ana I.

    Published in Annals of medicine (Helsinki) (01-04-2021)
    “…Throughout lifespan people are increasingly committed to take control of their own health and well-being, including fertility and sexual enhancement. Food…”
    Get full text
    Journal Article
  14. 14

    Slimming using magistral formulas: what are the risks? by Laúdo, Dulce, Fernandes, Tânia, Fernandes, Ana I.

    Published in Annals of medicine (Helsinki) (01-04-2021)
    “…Magistral formulas (MF) are prepared by the pharmacist for a given patient according to a prescription and following technical and scientific compounding…”
    Get full text
    Journal Article
  15. 15

    Teeth discolouration and prescribed slimming magistral formula: a case report by Fernandes, Tânia, Amorim, Armanda, Fernandes, Ana I.

    Published in Annals of medicine (Helsinki) (01-04-2021)
    “…Tooth discolouration is a common subject of aesthetic dissatisfaction for which patients seek dental care [ 1 , 2 ]. Discolouration can be extrinsic…”
    Get full text
    Journal Article
  16. 16

    Sulfonic Acid Derivatives in the Production of Stable Co-Amorphous Systems for Solubility Enhancement by da Costa, Nuno F, Santos, Inês A, Fernandes, Ana I, Pinto, João F

    Published in Journal of pharmaceutical sciences (01-12-2022)
    “…Co-amorphization is a promising approach to stabilize drugs in the amorphous form. Olanzapine, a poorly water-soluble drug was used in this study. Sulfonic…”
    Get more information
    Journal Article
  17. 17

    Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing by Figueiredo, Sara, Fernandes, Ana I, Carvalho, Fátima G, Pinto, João F

    Published in Journal of pharmacy and pharmacology (05-01-2022)
    “…The objective of this study was to develop a method for the preparation and characterization of paroxetine (PRX) tablets, obtained by coupling hot-melt…”
    Get full text
    Journal Article
  18. 18

    Characterisation and stability of co-amorphous systems containing olanzapine and sulphonic acids by Santos, Inês A., Bastos, Ana C., Pinto, João F., Fernandes, Ana I.

    Published in Annals of medicine (Helsinki) (01-04-2021)
    “…A large number of active pharmaceutical compounds currently under development are poorly water soluble, which can limit their bioavailability and results in…”
    Get full text
    Journal Article
  19. 19

    Co-formability, solubility enhancement and stability of olanzapine co-amorphous systems produced with different co-formers by Bastos, Ana C., Santos, Inês A., Pinto, João F., Fernandes, Ana I.

    Published in Annals of medicine (Helsinki) (01-04-2021)
    “…Strategies to address the problem of poorly water-soluble drugs encompass the conversion of a crystalline drug into an amorphous form to promote its apparent…”
    Get full text
    Journal Article
  20. 20

    Assessment of the stability of co-amorphous olanzapine in tablets by Costa, Nuno F. da, Pinto, João F., Fernandes, Ana I.

    Published in Annals of medicine (Helsinki) (01-04-2021)
    “…Amorphous and co-amorphous (CAM) materials have recently been used to improve oral bioavailability of drugs, by enhancing water solubility and dissolution rate…”
    Get full text
    Journal Article